Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-04-27A Multicenter Retrospective Study to Analyse the Impact of Treatment With Paliperidone Palmitate on Clinical Outcomes and Hospital Resource Utilization in Adult Patients With Schizophrenia in Portugal
-
CLINICAL_TRIALS study record update · 2025-04-27Korea Post-Marketing Surveillance of Invega Sustenna
-
CLINICAL_TRIALS study record update · 2025-04-27Clinical Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare Settings
-
CLINICAL_TRIALS study record update · 2025-04-27An Observational Study for Schizophrenia Relapse Prediction
-
CLINICAL_TRIALS study record update · 2025-04-25Predictors of Functional Remission in Discharged Patients With Schizophrenia After Long-term Drug Discontinuation: a Case-control Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-04-24Immunoinflammatory State Detection and Multimodal Brain Imaging and Electrophysiologic Changes in Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-04-22A Double-Blind, Cross-Over Placebo-Controlled and Active-Controlled Trial To Evaluate The Effect Of A Supratherapeutic Dose Of MK-8189 On The QTc Interval In Participants With Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-04-22Neuronal Effects of Exercise in Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-04-22Effects of Low-dose Levetiracetam on Clinical Symptoms, Cognition and Hippocampal Hyperactivity in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-04-18A Phase III, Multicenter, Randomized, Double-blind, Active-Controlled Study (Aripiprazole Tablets) to Evaluate the Efficacy and Safety of Brexpiprazole in the Treatment of Adults With Acute Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-04-18Testing TMS Enhancement of Visual Plasticity in Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-04-15Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders
-
CLINICAL_TRIALS study record update · 2025-04-11An Open-Label Study to Evaluate the Efficacy and Tolerability of Xanomeline/Trospium In First Episode/Early Phase Schizophrenia Patients
-
CLINICAL_TRIALS study record update · 2025-04-09Characterization of CB1 Receptors Using [11-C]OMAR
-
CLINICAL_TRIALS study record update · 2025-04-08Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments
-
CLINICAL_TRIALS study record update · 2025-04-08Do Antipsychotic Agents Induce Supersensitivity in Humans: A Combined PET/MRI Study in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-04-08A Multidose, Randomized, Double-Blind Study to Evaluate the Safety and Tolerability of Long-Acting Oral Risperidone (LYN-005) in Participants With Schizophrenia or Schizoaffective Disorder
-
CLINICAL_TRIALS study record update · 2025-04-03PET Imaging Study of α7 and α4β2-nAChR in Schizophrenia: Cognitive Relationships
-
CLINICAL_TRIALS study record update · 2025-04-02Effects of Different Doses of Buspirone Combined With Clozapine on Psychiatric Symptoms and Cognitive Function in Patients With Schizophrenia: A Randomised, Double-blind, Placebo-controlled Trial
-
CLINICAL_TRIALS study record update · 2025-04-02A Phase 3b, Open-label, Multicenter, Two-Period, Slow-titration and Food Effect Study to Assess the Safety and Efficacy of KarXT in Participants With DSM-5 Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-04-01A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-03-28The Muscarinic Hypothesis of Schizophrenia: an [11C]MK-6884 PET Study Study Protocol
-
CLINICAL_TRIALS study record update · 2025-03-28A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-03-28The Clinical and Functional Imaging Effects of Non-invasive Neuromodulation on Illness Awareness in Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-03-26Effects of Intermittent Theta Burst Stimulation (iTBS) on Increased Appetite Induced by Antipsychotics in Patients With Schizophrenia